LES Annual Meeting

Sep. 26, 2010-Sep. 29, 2010
Sheraton Chicago
Chicago, IL
www.lesusacanada.org/MainNav/Events/Meetings/2010annual.aspx

Description:

Ben Bonifant, Vice President and Head of the Business Development Practice at Campbell Alliance, and Jim McCarthy, Senior Vice President, Corporate Development, Expression Genetics, will co-present the results of the "LES Global BioPharmaceutical Royalty Rates & Deal Terms Survey." Also at the event, Gautam Aggarwal, Senior Practice Executive in Campbell Alliance's Business Development Practice, will present a session on "When to Do the Deal: How to Know When the Time is Right."

Abstract:

Results of the LES Global BioPharmaceutical Royalty Rates & Deal Terms Survey

Speakers:

Ben Bonifant, Vice President, Campbell Alliance

Jim McCarthy, Senior Vice President, Corporate Development, Expression Genetics

 

When to Do the Deal:  How to Know when the Time is Right

Speaker:

Gautam Aggarwal, Senior Practice Executive, Campbell Alliance

For licensing executives, the question of when to complete a deal can be a difficult one. For example, an out-licensor may wonder if it makes more sense to complete a deal earlier in development, thereby transferring more risk to its partner, but reducing its own financial rewards. On the other hand, the out-licensor may wonder if it’s better to wait until a later stage of development, exposing itself to greater risk of failure, but keeping the door open for greater financial returns.
 
Making this decision is difficult because the characteristics and risk profile of each asset varies. To make the best decision, licensing executives must identify that point in time at which risk and financial reward are optimally balanced.
 
This presentation will dissect this common problem facing licensing executives and outline an approach that decision-makers can apply to answer the question: “when should we do the deal?”

View Entire Event Calendar

Don't Miss